A conspicuous reduced plasma creatinine: the first presenting sign of Waldenstrom macroglobulinemia

References

1. Greenberg, N, Roberts, WL, Bachmann, LM, Wright, EC, Dalton, RN, Zakowski, JJ, et al.. Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and Jaffe method principles. Clin Chem 2012;58:391–401. https://doi.org/10.1373/clinchem.2011.172288.Search in Google Scholar

2. Metraiah, EH, Regan, H, Louw, J, Kidder, D. Deceiving proteins! A case of lymphoma and high creatinine. BMJ Case Rep 2017;bcr2016217946. https://doi.org/10.1136/bcr-2016-217946.Search in Google Scholar

3. McGill, MR, Vijayan, A, Trulock, EP, Wit, CA, Kohler, GD, Scott, MG. Falsely elevated plasma creatinine due to an immunoglobulin M paraprotein. Am J Kidney Dis 2016;68:789–92. https://doi.org/10.1053/j.ajkd.2016.05.014.Search in Google Scholar

4. Hummel, KM, von Ahsen, N, Kühn, RB, Kaboth, U, Grunwald, RW, Oellerich, M, et al.. Pseudohypercreatininemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenström’s macroglobulinemia. Nephron 2000;86:188–9. https://doi.org/10.1159/000045741.Search in Google Scholar

5. Rudofsky, G, Villalobos, M, Waldherr, R, Schaier, M, Zorn, M, Maimer, A, et al.. The case: renal failure in a male with Waldenström’s macroglobulinemia. Kidney Int 2010;77:371–2. https://doi.org/10.1038/ki.2009.465.Search in Google Scholar

6. Bakker, AJ, Mücke, M. Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention. Clin Chem Lab Med 2007;45:1240–3. https://doi.org/10.1515/CCLM.2007.254.Search in Google Scholar

7. Smogorzewska, A, Flood, JG, Long, WH, Dighe, AS. Paraprotein interference in automated chemistry analyzers. Clin Chem 2004;50:1691–3. https://doi.org/10.1373/clinchem.2004.037499.Search in Google Scholar